Primary care follow-up of radical prostatectomy patients: A regional New Zealand experience

Siegel, 2016, Cancer statistics, 2016, CA Cancer J Clin, 66, 7, 10.3322/caac.21332 Bill-Axelson, 2014, Radical prostatectomy or watchful waiting in early prostate cancer, N Engl J Med, 370, 932, 10.1056/NEJMoa1311593 DellOglio, 2016, Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancer, Urol Oncol, 34, 234.e13, 10.1016/j.urolonc.2015.11.018 Lu-Yao, 1996, Follow-up prostate cancer treatments after radical prostatectomy: a population-based study, J Nat Cancer Inst, 88, 166, 10.1093/jnci/88.3-4.166 Heidenreich, 2014, EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer, Eur Urol, 65, 467, 10.1016/j.eururo.2013.11.002 McGrath, 2016, Prostate cancer biomarkers: are we hitting the mark?, Prostate Int, 4, 130, 10.1016/j.prnil.2016.07.002 Watson, 2011, Views of health professionals on the role of primary care in the follow-up of men with prostate cancer, Fam Pract, 28, 647, 10.1093/fampra/cmr034 PSA testing for the pretreatment staging and posttreatment management: American Urological Association Prostate-Specific Antigen Best Practice Statement Update Panel. [Internet]. [cited 2016 Feb 10]. Available from: https://www.auanet.org/education/guidelines/prostate-specific-antigen.cfm. Heidenreich, 2014, EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013, Eur Urol, 65, 124, 10.1016/j.eururo.2013.09.046 Pound, 1999, Natural history of progression after PSA elevation following radical prostatectomy, JAMA, 281, 1591, 10.1001/jama.281.17.1591 van den Ouden, 1997, Tumour control according to pathological variables in patients treated by radical prostatectomy for clinically localized carcinoma of the prostate, Br J Urol, 79, 203, 10.1046/j.1464-410X.1997.33011.x Meiklejohn, 2016, The role of the GP in follow-up cancer care: a systematic literature review, J Cancer Surviv, 10.1007/s11764-016-0545-4 Perera, 2016, Sensitivity, specificity and predictors of positive 68Ga-PSMA PET: a systematic review and meta-analysis, Eur J Urol, 10.1016/j.eururo.2016.06.021 McIntosh, 2009, Follow-up care for men with prostate cancer and the role of primary care: a systematic review of international guidelines, Br J Cancer, 100, 1852, 10.1038/sj.bjc.6605080 Best Practice Advocacy Centre New Zealand. Following up prostate cancer in primary care. [cited 2016 Feb 21]. Available from: http://www.bpac.org.nz/BT/2012/October/prostate.aspx. Prostate cancer: diagnosis and treatment. NICE clinical guideline. Available from: guidance.nice.org.uk/cg175. Wilkinson, 2008, Approach to primary care follow-up of patients with prostate cancer, Can Fam Physician, 54, 204 Anderson, 2010, The benefits to nurse-led telephone follow-up for prostate cancer, Br J Nurs, 19, 1085, 10.12968/bjon.2010.19.17.78565 Lewis, 2009, Follow-up of cancer in primary care versus secondary care: systematic review, Br J Gen Pract, 59, e234, 10.3399/bjgp09X453567 Bulger, 2015, ‘Carrying on the way we are is becoming shambolic’ – an interview study with prostate cancer specialists about their usual practice of follow-up, J Clin Urol, 8, 240 Goodall, 2016, Initial experience of an algorithm-based protocol for the community follow-up of men with prostate cancer, BJU Int, 10.1111/bju.13446 DeKoekkoek, 2015, mHealth SMS text messaging interventions and to promote medication adherence: an integrative review, J Clin Nurs, 24, 2722, 10.1111/jocn.12918 Hamine, 2015, Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review, J Med Internet Res, 17, e52, 10.2196/jmir.3951 de Jongh, 2012, Mobile phone messaging for facilitating self-management of long-term illnesses, Cochrane Database Syst Rev, 12, CD007459 Perera, 2016, An update on focal therapy for prostate cancer, Nat Urol Rev, 13, 641, 10.1038/nrurol.2016.177